Aneurysm treatment using flow diversion could become the treatment of choice in the near future. While such side-wall aneurysm treatments have been studied in many publications and even implemented in selected clinical cases, bifurcation aneurysm treatment using flow diversion has not been addressed in detail. Using angiographic imaging, we evaluated treatment of such cases with several stent designs using patient-specific aneurysm phantoms. The aim is to find a way under fluoroscopic image guidance to place a low-porosity material across the aneurysm orifice while keeping the vessel blockage minimal. Three pre-shaped self-expanding stent designs were developed: the first design uses a middle-flap wing stent, the second uses a two-tapered-wing-ended stent, and the third is a slight modification of the first design in which the middle-flap is anchored tightly against the aneurysm using a standard stent. Treatment effects on flow were evaluated using high-speed angiography (30 fps) and compared with the untreated aneurysm. Contrast inflow was reduced in all the cases: 25% for Type 1, 63% for type 2 and 88% for Type 3. The first and the second stent design allowed some but substantially-reduced flow inside the aneurysm neck as indicated by the time-density curves. The third stent design eliminated almost all flow directed at the aneurysm dome, and only partial filling was observed. In the same time Type 1 and 3 delayed the inflow in the branches up to 100% compared to the untreated phantom. The results are quite promising and warrant future study.
Introduction
Intracranial Aneurysms (IA) subarachnoid hemorrhage continues to have high rates of morbidity and mortality for patients despite improving medical and surgical management. Currently, there is an intense effort to improve endovascular aneurysm treatment using stents as hemodynamics modifiers. Arterial stents have historically been used as lumen re-shapers of stenosed arteries or for large-neck intracranial aneurysm coil support. Recently, stents have been applied as hemodynamic modifiers and intra-aneurysmal thrombosis promoters in animal model aneurysms [1] [2] [3] [4] [5] [6] [7] [8] [9] and specific human cases [10] [11] [12] [13] (pipeline embolization device); however, the current designs, while effective in some sidewall aneurysms, are inappropriate for usage in the case of the bifurcation aneurysms where approaches such as a y-stenting technique might be needed. Another important consideration in using stent-like flow modifiers is the potential blockage of nearby arterial branches could cause severe strokes. Initial clinical implementation of such flow devices in basilar bifurcation aneurysms treatment caused complications in 25% of the cases. 11 The late ischemic events affecting perforating arteries occurring after FD (Flow Diverter) implantation, indicate that the device usage should be restricted to otherwise untreatable aneurysms in this location. Thus currently there is essentially no device available for effective treatment of the most critical bifurcation aneurysms.
We envisage a new approach for bifurcation IA treatment using stent designs that emerged from our previous experience with building a flow modifying Asymmetric Vascular Stent (AVS), for side-wall aneurysm treatment [1] [2] [3] [4] [5] 14 . The new approach uses the Nitinol pre-shaping properties to design a stent which will serve as a scaffold for a low porous area for aneurysm ostium blockage while maintaining the adjacent arteries un-blocked. We propose to use new pre-shaped, selfexpanding, flow-diverting stents to treat bifurcation aneurysm phantom models, and study their effect on the flow in the aneurysm dome and on the adjacent branches.
In general the first step in the analysis of the flow modification caused by such new devices is to study the problem in reproducible neuro arterial flow-like conditions using computational simulations or aneurysm phantom experiments.
The second choice will involve flow measurements using some tracking agent such as particles (Particle Image Velocimetry, PIV) or contrast (Digital Subtraction Angiography, DSA).
Invariably, all models based on DSA contrast analysis rely on selecting a small region of interest over the aneurysm region and monitor the variation of the contrast over a period of time. Contrast presence in the aneurysm dome is recorded as a function of time and a time density curve (TDC) is derived. The method is repeated for untreated and device-treated aneurysms and differences are later reported. The goal of this paper is to develop and investigate the feasibility of bifurcation IA treatment using pre-shaped, selfexpanding, flow-diverting stents. The flow changes in the treated aneurysm and adjacent branches are rerecorded using angiographically derived TDC's.
Materials and methods

Proposed treatment
Self-expanding stents were made from Nitinol tubing using a CAD design similar to that of current intracranial selfdeploying stents. Nitinol (NiTi) tubing with 1.5 mm diameter and 100 micron wall thickness was machine laser cut (LaserAge Inc., Waukegan, IL). The stents were heat treated to fit the patient-specific aneurysm bifurcation geometry and to provide a support for a low-porosity patch for aneurysm neck/orifice coverage. After the stents were heat treated and the geometry was set, they underwent a chemical polishing treatment. On the stent wings we attached a PTFE porous patch using a method previously established by our group 5 .
We built two different stent geometries which will be referred to as 'tapered wing-ended' stent and 'middle ended wing' stent shown in Figure 1 (a) and (c), respectively. Figure 1 (b) shows the tapered wing-ended stent used with structural support and Fig. 1(d) shows two type 2 stents in a bridge formation. We have considered three situations for stent treatment as presented in Figure 2 (b-d). Each treated case is referred as a treatment type: Type 1 for (b), Type 2 for (c) and Type 3 for (d). In Figure 2 (a) we show the untreated aneurysms which is referred as the control. Type 1 aneurysm treatment is done using one middle-wing stent. The stent is designed to have the proper curvature so as to fit the vessel geometry; once the stent is deployed the middle wing will cover the aneurysm ostium. This simple approach might suffer from various potential difficulties. The first concern is that, for large neck aneurysms the wing may not be strong enough to withstand the pulsatile blood effects and might start oscillating, causing damage to the aneurysm or specifically to the aneurysm neck. The other stent treatments are designed to respond to these challenges. In Type 2 treatment, we propose to use two tapered wingended stents Figure 1 (c). The wings are relatively short and the jailing of the daughter arteries is eliminated. The stents are placed in such a way that they create a bridge across the aneurysm neck as shown in Figure 1 (d). In Type 3 treatment we use a y-stenting technique using a Type 1 stent and a normal stent, where the normal stent is used to anchor the wing across the aneurysm neck for a tight, solid coverage of the aneurysm neck. This configuration, however could cause additional branch jailing. We are particularly interested in these stenting techniques for basilar terminal aneurysms where the main basilar artery is populated with many small perforator vessels proximal to the bifurcation. A patient-specific phantom ( Figure 3 ) of a basilar tip aneurysm was created using 3D data generated from rotational DSA. The geometry was segmented and a CAD-model was created. The geometry was sent to a rapidprototyping facility and a wax model was created, which later was embedded in an elastomer and melted after the curing of the elastomer 1 .
Experimental Setup
The stents were inserted in 3 Fr catheters similar to the current microcatheter used for self-deployable neuro-stent delivery. A flow circuit was built as shown in Figure 3 . A variable speed pump (Cole Parmer, Vernon Hills, IL) was used to pump water through the phantom; the speed was adjusted to approximate 40 cm/s yielding a Reynolds number of 600 in the main artery before contrast injection. The contrast was injected using a 4 Fr Catheter (Boston Scientific, Natick, MA) connected to an automatic injector Mark V ProVis (MedRad, Warrendale, PA). The working fluid was a mixture of 40/60 glycerol/water with a density of 1.1 g/cm 3 and viscosity of 3.72 Cp. Six different time density curves were acquired for each stented and control phantoms. The proximal line was used to derive the input bolus distribution; four outlet vessels were also monitored as shown in Figure 3 (right) and the aneurysm ROI.
The delay between the bolus arrival at the proximal markers and the four outlets was measured. Bolus arrival was calculated using the time-of leading half-peak opacification 16 . According to this method the bolus is considered to have arrived when the time-density curve achieves half of its peak density for the first time. The proximal line TDC for treated phantoms and the control was compared using the square of Pearson product moment correlation coefficient (r^2) to verify similar flow conditions and bolus distribution.
Results
For each treatment type and control we acquired 3 angiograms separated only by a few seconds in between. The inlet and the four outlet monitoring points were not changed between phantoms (Figure 3 ). Time density curves were derived for each location. Comparison of the control input bolus TDC with the three treated cases yielded an r^2 of 0.90, 092 and 0.84. The input bolus comparison between the three stented cases yielded an R^2 above 0.98. The time delay required for the bolus to arrive from the proximal to each of the outputs is indicated in Table 1 . For the control phantom the bolus required about 0.195±0.061seconds corresponding to about 6 frames±2 frames. The average arrival delay time to the four output locations increase for the Type 1 and Type 3 cases and was almost identical, within the error limits(less than a frame), for Type 2. The same aspect can be visualized qualitatively in Figure 6 , in each of the sequences the first image shows the arrival of the bolus, the following frames are the immediate 5 frames acquired. For the control it can be seen that after 3 frames the arteries are almost fully filled. For the treated cases full branch filling is achieved after five frames for Type 1, after 3 frames for Type 2. For the 3 rd type full branch filling is not achieved after five frames, the only branches filled are distal right and left branch. The qualitative assessment of aneurysmal flow modifications are done using the frames displayed in figure 6 . Figure 6 displays flow details immediately after bolus arrival and the subsequent frames are taken at equal intervals. The angiographic snapshots of the control in Figure 6 indicate the flow directed at the left side of the aneurysm dome followed by a quick filling of the aneurysm dome starting from the left side to the right. This behavior could be explained only through the presence of a vortex like flow in the aneurysm dome, however this conclusion is rather a speculation, since the detector resolution doesn't allow fine visualization of the flow patterns in the aneurysmal dome. Aneurysmal flow diversion is observed in all of the three types of treatment. For Type 1 some filling of the aneurysmal dome is observed within the six frames, the inflow is still localized at left side of the aneurysm; however, the filling rate is much smaller indicating a significant deflection of the flow at the aneurysmal ostium. The observed deflection and aneurysmal flow deflection is improved for the type 2 and 3 treatment. For the 3 rd type treatment the inflow is localized at the left side of the aneurysmal ostium and the contrast does not disperse fully in the aneurysmal dome after 5 frames indicating a slow recirculation in the aneurysmal dome. Also the bolus arrival delay can be easily observed for the stented cases.
The Time Density Curves for the aneurysm volume obtained for the four cases are shown in Figure 7 . Contrast inflow was reduced in all the cases: 25% for the Type 1, 63% for the Type 2 and 88% for the Type 3. It can be observed that the most severe effect on flow redirection has occurred in the aneurysm treated with Type 3 approach. For the other two there is potential infiltration of contrast in the aneurysm dome, and additional work needs to be done to optimize these stent designs.
Discussions
In this experiment we used DSA runs to analyze contrast flow and establish if the proposed aneurysm treatment approach is feasible. The angiographic investigation tools used in this research are well established, DSA being virtually the gold standard for such studies. However, the work presented is the first to address angiographic analysis of patient specific bifurcation intracranial aneurysms treated with a flow diverting stents specially designed for this relatively complicated geometry. Besides the flow aspect, which is our main concern, the experiment brings two other novelties. First this is one of the first studies where a self expanding stent has been customized to fit a patient specific geometry derived from a diagnostic CTA, and where there was an investigation of the flow disturbance in the nearby branches following the stent placement. Based on the patient arterial vasculature we were able to customize a self expanding stent using the pseudo elastic properties of the Nitinol alloy. Stent fabrication is relatively straight forward and can be done in approximately 24 hours. The longest part of stent preparation is polyurethane curing; thermal pre-shaping and other steps take in general less than an hour. This relatively short time could imply the possibility for patient specific stents in non-emergency cases such as unruptured aneurysms. Verification of the identical input conditions based on input bolus comparison revealed acceptable bolus distributions between the control and the treated samples and almost identical distributions for the treated cases. A systematic enlargement of the bolus in time was observed for the treated cases, despite maintaining the same flow rate and injection conditions. The possible reason for such behavior could be related to the additional flow resistance posed by the stents within the phantom. The specially designed stents are extremely porous everywhere except the aneurysm ostium. The magnitude of the effect that the asymmetric stent had on the adjacent branches was significant but not unexpected. Neurosurgeons often report delayed flow in the arterial branches jailed by the neuro stents. As can be seen in Figure 2 Type 1 and Type 3 are the most susceptible of disturbing the flow in the collateral branches. Type 3 treatment especially places two stents in the basilar trunk hence the chance of branch occlusion is larger. In addition in Type 3 after support stent placement one of the terminal branches is jailed too. These aspects explain the increase delay observed in the Type 3 treatment in both branches and daughter vessels. Aneurysmal flow reduction after treatment has been less than what we have previously reported. [1] [2] [3] [4] In general we measured at least one order of magnitude decrease in the aneurysm dome contrast presence after placement of the asymmetric stents. Also in animal study we performed we observed that those aneurysms not following this drastic drop in general were showing different levels of incomplete healing after four weeks follow up. These results are due to the special geometry that the terminal bifurcation aneurysms present. For this kind of malformation the impinging jet is perpendicular to the aneurysm ostium unlike the side wall aneurysms we studied previously where the input jet was rather directed at some angle and hence for side wall aneurysms the impingent jet is easier to deflect. Increased flow deflection is relatively easily achievable by changing the physical properties of the ostium covering material. Overall this experiment has proven that the proposed intracranial bifurcation aneurysm treatment is achievable. Stents were placed with high precision in the phantom and the special design insured ostium coverage by the low porous patch. Delayed flow within the branches can be eliminated with better stent design; the stents were mimicking the current design of intracranial stents which are used for angioplasties or coil-holding in case of large neck aneurysms. In future designs we can minimize the amount of material in the high porous region because the purpose of these scaffolds is not in propping up an arterial wall or a coil mass but only in localizing the low porosity patch region over the aneurysm ostium.
Conclusions and Significance
Angiographic analysis of the proposed treatment for the bifurcation aneurysms indicated significant flow reduction using the new stent designs. The current results are encouraging for continued development.
